Showing results (131-140 of 484) with videos related to

Sort By:
Pageof 49
Atherosclerosis|October 1, 1995
Changes in epitope exposition of apolipoprotein A-I on the surface of high density lipoproteins after phospholipase A2 treatmentM Menschikowski, U Hempel, G Dinnebier, et al.
Pharmacoeconomics|March 8, 1998
Evaluation of the potential clinical and economic effects of bodyweight stabilisation with acarbose in patients with type 2 diabetes mellitus. A decision-analytical approachK Banz, R Dinkel, M Hanefeld, et al.
Current Medical Research and Opinion|July 19, 2006
Glycemic control and treatment failure with pioglitazone versus glibenclamide in type 2 diabetes mellitus: a 42-month, open-label, observational, primary care studyM Hanefeld, A Pfützner, T Forst, et al.
Diabetes Research and Clinical Practice|February 1, 1996
Determinants for coronary heart disease in non-insulin-dependent diabetes mellitus: lessons from the diabetes intervention studyM Hanefeld, H Schmechel, U Julius, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 26, 2006
Relationship between diurnal glucose levels and HbA1c in type 2 diabetesF Pistrosch, C Koehler, J Wildbrett, et al.
Thrombosis Research|September 7, 2000
Frequency of polymorphisms in the B-domain of factor V gene in APC-resistant patientsH Kostka, G Siegert, T Schwarz, et al.
Atherosclerosis|December 1, 1995
Secretory group II phospholipase A2 in human atherosclerotic plaquesM Menschikowski, M Kasper, P Lattke, et al.
Diabetes|December 4, 1998
In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose toleranceJ Pietzsch, U Julius, S Nitzsche, et al.
European Journal of Clinical Investigation|August 1, 1994
Efficacy of alpha-glucosidase inhibitors on lipids in NIDDM subjects with moderate hyperlipidaemiaW Leonhardt, M Hanefeld, S Fischer, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 10, 2011
Effects of pioglitazone versus simvastatin on biomarkers of inflammation in patients on high cardiovascular riskM Hanefeld, F Schaper, D Appelt, et al.
Pageof 49